J3101 HCPCS code: Injection, tenecteplase, 1 mg
J3101 is the HCPCS Level II code for injection, tenecteplase, 1 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 50 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2009-01-01 |
| Last action effective | 2009-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 50 | Prescribing Information |
| practitioner claims | 50 | Prescribing Information |
What changed for J3101
- 2009-01-01: J3101 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3101?
J3101 is the HCPCS Level II code for injection, tenecteplase, 1 mg. Short descriptor: "Tenecteplase injection".
Does Medicare cover J3101?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3101 can be billed per day?
50 on outpatient hospital claims; 50 on practitioner claims (NCCI medically unlikely edits).
Related J31 codes
- J3105 — Injection, terbutaline sulfate, up to 1 mg
- J3110 — Injection, teriparatide, 10 mcg
- J3111 — Injection, romosozumab-aqqg, 1 mg
- J3120 — Injection, testosterone enanthate, up to 100 mg
- J3121 — Injection, testosterone enanthate, 1 mg
- J3130 — Injection, testosterone enanthate, up to 200 mg
- J3140 — Injection, testosterone suspension, up to 50 mg
- J3145 — Injection, testosterone undecanoate, 1 mg
- J3150 — Injection, testosterone propionate, up to 100 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3101
- Watch J3101 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3101
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.